|
Re: ...isn't this interesting...
|
2
|
Resverlogix Corp.
|
Jul 07, 2015 01:04PM
|
|
Re: For The Record
|
2
|
Zenith Epigenetics
|
Sep 28, 2022 07:52AM
|
|
Re: Update
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 10:34AM
|
|
Re: Update
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 10:37AM
|
|
Re: Could it be
|
2
|
Zenith Epigenetics
|
Oct 27, 2023 11:05AM
|
|
Re: $2.00 financing
|
2
|
Resverlogix Corp.
|
Mar 22, 2017 07:39PM
|
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 25, 2023 07:31AM
|
|
Re: Long Covid remains a big challenge
|
2
|
Resverlogix Corp.
|
Jul 25, 2023 07:34AM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 22, 2021 04:08PM
|
|
Re: Questions/comments sent to IR/Chris for Don to review & answer …
|
2
|
Resverlogix Corp.
|
Jul 29, 2024 07:24PM
|
|
Re: PNAS
|
2
|
Resverlogix Corp.
|
Jan 02, 2021 11:03AM
|
|
Re: AGM Voting
|
2
|
Zenith Epigenetics
|
Oct 17, 2022 09:38AM
|
|
Re: 5 million shares
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 10:15AM
|
|
Re: Buyout?......
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 03:00PM
|
|
Re: Long Covid remains a big challenge
|
2
|
Resverlogix Corp.
|
Jul 25, 2023 01:02PM
|
|
Re: Shareholder Value
|
2
|
Zenith Epigenetics
|
Aug 07, 2021 08:46AM
|
|
Re: From General360 On SH....Hepalink halted pending asset acquisition
|
2
|
Resverlogix Corp.
|
Jun 05, 2017 03:22PM
|
|
Re: Round one
|
2
|
Resverlogix Corp.
|
Jan 28, 2022 07:37AM
|
|
How might the headline read with a successful PIII?
|
2
|
Resverlogix Corp.
|
May 28, 2019 09:46AM
|
|
Re: Questrade
|
2
|
Zenith Epigenetics
|
Jan 05, 2024 11:25PM
|
